Get started
Author

Ville Varmavuo

Observed names: V. Varmavuo, V., Varmavuo, Varmavuo Ville, Varmavuo, Ville
Observed institutions: University of Eastern Finland, Helsinki University Hospital, Kuopio University Hospital, Eastern Finland Laboratory Center, Tampere University Hospital, Kymenlaakson keskussairaala
ORCID: 0000-0001-5070-6018
Observed ORCID: 0000-0001-5070-6018
OpenAlex ID: A5078430570
Reproducibility of infrared thermography measurements in healthy individuals
2008 · Nina Zaproudina, Ville Varmavuo, et al. · Physiological Measurement · 252
PDF
CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients
2012 · Ville Varmavuo, Pentti Mäntymaa, et al. · Transfusion · 34
Blood graft composition after plerixafor injection in patients with NHL
2012 · Ville Varmavuo, Pentti Mäntymaa, et al. · European Journal Of Haematology · 33
Blood graft lymphocyte subsets after plerixafor injection in non‐Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte–colony‐stimulating factor
2012 · Ville Varmavuo, Pentti Mäntymaa, et al. · Transfusion · 31
PDF
Engraftment and outcome after autologous stem cell transplantation in plerixafor‐mobilized non‐ H odgkin's lymphoma patients
2013 · Ville Varmavuo, Johanna Rimpiläinen, et al. · Transfusion · 30
Kinetics of blood CD34+ cells after chemotherapy plus G-CSF in poor mobilizers: Implications for pre-emptive plerixafor use
2012 · E. Jantunen, V. Varmavuo, et al. · Annals of Hematology · 30
Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study
2020 · Antti Turunen, Jaakko Valtola, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 23
Blood graft cellular composition and posttransplant recovery in non‐Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison
2015 · Jaakko Valtola, Ville Varmavuo, et al. · Transfusion · 23
Pre-emptive plerixafor injection increases blood neutrophil, lymphocyte and monocyte counts in addition to CD34+ counts in patients with non-Hodgkin lymphoma mobilizing poorly with chemotherapy plus G-CSF: Potential implications for apheresis and graft composition
2012 · V. Varmavuo, P. Mäntymaa, et al. · Transfusion and Apheresis Science · 19
Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low‐dose cyclophosphamide: a randomized comparison
2016 · Jaakko Valtola, Raija Silvennoinen, et al. · Transfusion · 18
Plerixafor for mobilization of blood stem cells in autologous transplantation: an update
2014 · Esa Jantunen, Ville Varmavuo · Expert Opinion on Biological Therapy · 18
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study
2021 · Antti Turunen, Raija Silvennoinen, et al. · Transfusion · 17
Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance
2016 · Jaakko Valtola, Ville Varmavuo, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 17
Plerixafor injection: a hematopoietic stem cell mobilizer in non-Hodgkin lymphoma and multiple myeloma
2016 · Esa Jantunen, Ville Varmavuo, et al. · Expert Review of Hematology · 16
Mobilization characteristics, blood graft composition, and outcome in diffuse large B‐cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study
2020 · Anu Partanen, Antti Turunen, et al. · Transfusion · 13
Impact of lenalidomide‐based induction therapy on the mobilization of CD34+ cells, blood graft cellular composition, and post‐transplant recovery in myeloma patients: a prospective multicenter study
2017 · Anu Partanen, Jaakko Valtola, et al. · Transfusion · 13
PDF
Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
2023 · Esa Jantunen, Anu Partanen, et al. · Transfusion Medicine and Hemotherapy · 12
CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non‐Hodgkinʼs lymphoma patients: results of the prospective multicenter GOA study
2020 · Antti Turunen, Anu Partanen, et al. · Transfusion · 12
PDF
Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study
2018 · Jaakko Valtola, Raija Silvennoinen, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11
Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly
2017 · A. Partanen, J. Valtola, et al. · Annals of Hematology · 10
Cost analysis of a randomized stem cell mobilization study in multiple myeloma
2016 · Ville Varmavuo, Raija Silvennoinen, et al. · Annals of Hematology · 9
Impact of plerixafor use in the mobilization of blood grafts for autologous hematopoietic cell transplantation
2024 · Esa Jantunen, Antti Turunen, et al. · Transfusion · 8
Comparison of CD34 + cell mobilization, blood graft cellular composition, and post‐transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low‐dose cyclophosphamide: A prospective multicenter study
2021 · Partanen Anu, Turunen Antti, et al. · Transfusion · 8
Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients
2019 · Esa Jantunen, Ville Varmavuo, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non‐Hodgkin lymphoma patients
2018 · A. Partanen, J. Valtola, et al. · Transfusion · 8
PDF
Works count: 49
Citation count: 709
H-index: 14
I10-index: 20
Year
Topic
Type